These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3129746)

  • 1. The relevance of pharmacological studies to sleep research in psychiatry.
    Janssen PA
    Pharmacopsychiatry; 1988 Jan; 21(1):33-7. PubMed ID: 3129746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?
    Janssen PA
    J R Soc Med; 1987 Jul; 80(7):409-13. PubMed ID: 3116237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of new antipsychotic drugs].
    Vanden Bussche G; Gelders YG; Heylen SL
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):13-25. PubMed ID: 2127339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study to establish the indication for the selective S2 antagonist ritanserin.
    Klieser E; Strauss WH
    Pharmacopsychiatry; 1988 Nov; 21(6):391-3. PubMed ID: 3149751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone].
    Niemegeers CJ; Awouters F; Janssen PA
    Encephale; 1990; 16(2):147-51. PubMed ID: 1693560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL; Hoppenbrouwers ML; Gelders YG; Reyntjens AJ
    Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin (R 55667) an original thymosthenic.
    Hoppenbrowers ML; Gelders Y; Vanden Bussche G
    Boll Chim Farm; 1986 Dec; 125(12):136S-147S. PubMed ID: 3109453
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM; Marini S; Gregori S
    Int J Clin Pharmacol Res; 1987; 7(2):111-9. PubMed ID: 3108171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
    Idzikowski C; Mills FJ; Glennard R
    Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5 HT2 antagonists and carpipramine].
    Sechter D; Loo H
    Rev Prat; 1990 Nov; 40(25):2363-5. PubMed ID: 2124722
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy.
    Lammers GJ; Arends J; Declerck AC; Kamphuisen HA; Schouwink G; Troost J
    Sleep; 1991 Apr; 14(2):130-2. PubMed ID: 1678203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritanserin and alcohol abuse and dependence.
    Meert TF
    Alcohol Alcohol Suppl; 1994; 2():523-30. PubMed ID: 8974378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin antagonism in panic disorder: an open trial with ritanserin.
    Griez E; Pols H; Lousberg H
    Acta Psychiatr Belg; 1988; 88(5-6):372-7. PubMed ID: 3152708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
    Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
    Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosthenic agents, a novel approach in the treatment of schizophrenia.
    Gelders YG
    Br J Psychiatry Suppl; 1989 Jul; (5):33-6. PubMed ID: 2481482
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ritanserin on sleep disturbances of dysthymic patients.
    Paiva T; Arriaga F; Wauquier A; Lara E; Largo R; Leitao JN
    Psychopharmacology (Berl); 1988; 96(3):395-9. PubMed ID: 3146774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.